Middle East Pharmaceutical Industries Company (TADAWUL:4016)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
134.30
+3.10 (2.36%)
Oct 8, 2025, 2:45 PM AST

TADAWUL:4016 Ratios and Metrics

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2,6802,436----
Enterprise Value
2,7172,496----
Last Close Price
134.00119.60----
PE Ratio
28.8530.51----
Forward PE
26.7524.86----
PS Ratio
6.206.18----
PB Ratio
6.966.62----
P/TBV Ratio
8.087.67----
P/FCF Ratio
93.85100.97----
P/OCF Ratio
57.6069.02----
EV/Sales Ratio
6.296.33----
EV/EBITDA Ratio
24.3225.19----
EV/EBIT Ratio
26.4127.95----
EV/FCF Ratio
95.13103.45----
Debt / Equity Ratio
0.160.180.200.300.330.25
Debt / EBITDA Ratio
0.540.660.731.111.050.72
Debt / FCF Ratio
2.132.710.861.443.445.49
Asset Turnover
0.840.800.760.700.73-
Inventory Turnover
1.661.681.441.371.45-
Quick Ratio
1.941.851.491.361.591.52
Current Ratio
2.832.652.362.222.302.66
Return on Equity (ROE)
25.72%23.67%22.44%21.72%25.52%-
Return on Assets (ROA)
12.52%11.39%10.83%10.10%12.09%-
Return on Capital (ROIC)
15.81%13.91%13.21%12.06%14.23%-
Return on Capital Employed (ROCE)
24.10%22.70%23.40%22.30%25.40%28.20%
Earnings Yield
3.47%3.28%----
FCF Yield
1.07%0.99%----
Dividend Yield
1.91%1.67%----
Payout Ratio
43.04%18.79%54.69%61.14%56.12%49.80%
Total Shareholder Return
1.91%1.67%----
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.